Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study

P. Osterlund; S. Kinos; P. Pfeiffer; T. Salminen; J. J.M. Kwakman; J. E. Frödin; C. H. Shah; H. Sorbye; R. Ristamäki; P. Halonen; L. M. Soveri; E. Heervä; A. Ålgars; M. Bärlund; H. Hagman; R. McDermott; M. O'Reilly; R. Röckert; G. Liposits; R. Kallio; P. Flygare; A. J. Teske; E. van Werkhoven; C. J.A. Punt; B. Glimelius

doi:10.1016/j.esmoop.2022.100427

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study

P. Osterlund
, S. Kinos
, P. Pfeiffer
, T. Salminen
, J. J.M. Kwakman
, J. E. Frödin
, C. H. Shah
, H. Sorbye
, R. Ristamäki
, P. Halonen
, L. M. Soveri
, E. Heervä
, A. Ålgars
, M. Bärlund
, H. Hagman
, R. McDermott
, M. O'Reilly
, R. Röckert
, G. Liposits
, R. Kallio

P. Flygare, A. J. Teske, E. van Werkhoven, C. J.A. Punt, B. Glimelius

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Article number	100427
Journal	ESMO open
Volume	7
Issue number	3
Number of pages	10
ISSN	2059-7029
DOIs	https://doi.org/10.1016/j.esmoop.2022.100427
Publication status	Published - Jun 2022
MoE publication type	A1 Journal article-refereed

Bibliographical note

Publisher Copyright:
© 2022 The Author(s)

Fields of Science

cardiac toxicity
cardiotoxicity
colorectal cancer
fluoropyrimidines
gastrointestinal cancer
S-1
3122 Cancers

Access to Document

10.1016/j.esmoop.2022.100427

1-s2.0-S2059702922000485-mainFinal published version, 587 KBLicence: CC BY

Cite this

Osterlund, P., Kinos, S., Pfeiffer, P., Salminen, T., Kwakman, J. J. M., Frödin, J. E., Shah, C. H., Sorbye, H., Ristamäki, R., Halonen, P., Soveri, L. M., Heervä, E., Ålgars, A., Bärlund, M., Hagman, H., McDermott, R., O'Reilly, M., Röckert, R., Liposits, G., ... Glimelius, B. (2022). Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study. ESMO open, 7(3), Article 100427. https://doi.org/10.1016/j.esmoop.2022.100427

@article{73e74f78d21149e2973df6893bfc1853,

title = "Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study",

keywords = "cardiac toxicity, cardiotoxicity, colorectal cancer, fluoropyrimidines, gastrointestinal cancer, S-1, 3122 Cancers",

author = "P. Osterlund and S. Kinos and P. Pfeiffer and T. Salminen and Kwakman, \{J. J.M.\} and Fr{\"o}din, \{J. E.\} and Shah, \{C. H.\} and H. Sorbye and R. Ristam{\"a}ki and P. Halonen and Soveri, \{L. M.\} and E. Heerv{\"a} and A. {\AA}lgars and M. B{\"a}rlund and H. Hagman and R. McDermott and M. O'Reilly and R. R{\"o}ckert and G. Liposits and R. Kallio and P. Flygare and Teske, \{A. J.\} and \{van Werkhoven\}, E. and Punt, \{C. J.A.\} and B. Glimelius",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s)",

year = "2022",

month = jun,

doi = "10.1016/j.esmoop.2022.100427",

language = "English",

volume = "7",

journal = "ESMO open",

issn = "2059-7029",

publisher = "BMJ Publishing Group Ltd",

number = "3",

}

Osterlund, P, Kinos, S, Pfeiffer, P, Salminen, T, Kwakman, JJM, Frödin, JE, Shah, CH, Sorbye, H, Ristamäki, R, Halonen, P, Soveri, LM, Heervä, E, Ålgars, A, Bärlund, M, Hagman, H, McDermott, R, O'Reilly, M, Röckert, R, Liposits, G, Kallio, R, Flygare, P, Teske, AJ, van Werkhoven, E, Punt, CJA & Glimelius, B 2022, 'Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study', ESMO open, vol. 7, no. 3, 100427. https://doi.org/10.1016/j.esmoop.2022.100427

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study. / Osterlund, P.; Kinos, S.; Pfeiffer, P. et al.
In: ESMO open, Vol. 7, No. 3, 100427, 06.2022.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours

T2 - a multicentre retrospective observational cohort study

AU - Osterlund, P.

AU - Kinos, S.

AU - Pfeiffer, P.

AU - Salminen, T.

AU - Kwakman, J. J.M.

AU - Frödin, J. E.

AU - Shah, C. H.

AU - Sorbye, H.

AU - Ristamäki, R.

AU - Halonen, P.

AU - Soveri, L. M.

AU - Heervä, E.

AU - Ålgars, A.

AU - Bärlund, M.

AU - Hagman, H.

AU - McDermott, R.

AU - O'Reilly, M.

AU - Röckert, R.

AU - Liposits, G.

AU - Kallio, R.

AU - Flygare, P.

AU - Teske, A. J.

AU - van Werkhoven, E.

AU - Punt, C. J.A.

AU - Glimelius, B.

PY - 2022/6

Y1 - 2022/6

KW - cardiac toxicity

KW - cardiotoxicity

KW - colorectal cancer

KW - fluoropyrimidines

KW - gastrointestinal cancer

KW - S-1

KW - 3122 Cancers

U2 - 10.1016/j.esmoop.2022.100427

DO - 10.1016/j.esmoop.2022.100427

M3 - Article

C2 - 35798468

AN - SCOPUS:85127304914

SN - 2059-7029

VL - 7

JO - ESMO open

JF - ESMO open

IS - 3

M1 - 100427

ER -